Compare UROY & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | UROY | DIAX |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.2M | 528.0M |
| IPO Year | N/A | N/A |
| Metric | UROY | DIAX |
|---|---|---|
| Price | $4.01 | $15.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 96.6K |
| Earning Date | 12-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,266,447.00 | N/A |
| Revenue This Year | $195.97 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.29 | N/A |
| 52 Week Low | $1.43 | $12.80 |
| 52 Week High | $5.37 | $15.12 |
| Indicator | UROY | DIAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.09 | 66.06 |
| Support Level | $3.63 | $14.89 |
| Resistance Level | $3.87 | $15.07 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 95.60 | 100.00 |
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.